Cancer clinical trials in the region Auvergne-Rhône-Alpes
518 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Sarcoma and GIST
Thymus cancer
Penile cancer and germ cell tumors
Cervical / Vulvar / Vaginal cancer
Small intestine and appendix cancer
Thyroid and adrenal gland cancer
Skin cancer
#NCT02029001
#2012-004510-34
Cohorte Durvalumab + Tremelimumab
Required disease stage
Locally Advanced
Metastatic
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
1
2
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Immunotherapy
Bispecific T-cell engager antibodies
7 recruiting sites
Centre Léon Bérard
Phase 2
Penile cancer and germ cell tumors
#NCT05529251
#2024-514636-25-00
Required histologic types
Germ cell tumor
Required histologic sub types
Pure seminoma
Required disease stage
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Required primary sites
Testis
Required IGCCCG prognostic scores
Good prognosis
Excluded previous treatments at localized stage
Surgery
Radiotherapy
Excluded previous treatments at advanced or metastatic stage
Chemotherapy
Radiotherapy
12 recruiting sites
Centre Léon Bérard
Phase 2
Lymphoma
#NCT06806033
#2024-516791-15-00
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Indolent transformed lymphoma
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
4 recruiting sites
Hoffmann-La Roche
Phase 2
Lymphoma
Brain tumors / Central nervous system tumors
#NCT07015242
#2025-521144-38-00
Required histologic types
B cell lymphoma
Other primary CNS tumor
Required histologic sub types
Primary cerebral lymphoma
Primary CNS lymphoma
Required central nervous system lesions
Actives
Required number of previous lines of therapy
None
Excluded previous treatments
Car-T
Allogeneic stem cell transplant
12 recruiting sites
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
Endometrial cancer
Sarcoma and GIST
#NCT03624244
Required histologic types
Soft tissue sarcoma
Required histologic sub types
Other
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Hormone therapy
19 recruiting sites
Centre Léon Bérard
Phase 2
Stomach and esophageal cancer
#NCT07546812
#2025-524095-27-00
Required histologic types
Stomach
Oesogastric junction
Esophagus
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Immunotherapy
Chemotherapy
Excluded genetic anomalies
HER2
MSI/dMMR
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
2 recruiting sites
Gilead Sciences
Phase 2
Stomach and esophageal cancer
#NCT06059495
Required histologic types
Stomach
Oesogastric junction
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Immunotherapy
Chemotherapy
Radiotherapy
11 recruiting sites
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Breast cancer
#NCT06358573
#2024-512511-49-00
Required HER2 statuses
HER2 Negative
Required HR statuses
HR Negative
Required disease stage
Localized
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
1 recruiting site
Institut suisse du cancer
Phase 2
Lung cancer
#NCT06656598
#2024-517316-29-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
ALK
EGFR
ROS-1
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Chemotherapy
25 recruiting sites
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Lung cancer
#NCT06840834
#2024-519052-82-00
Required histologic types
Mesothelium
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
1
2
Required previous treatments at advanced or metastatic stage
Immunotherapy
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
17 recruiting sites
Intergroupe Francophone de Cancérologie Thoracique